LONG COVID-19

Clinical trials for LONG COVID-19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID-19 trials appear

Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 14

Could a gut pill ease long COVID? new trial tests larazotide

Disease control Ongoing

This Phase 2a study tests whether larazotide, a drug that tightens the gut lining, can reduce long COVID symptoms in people aged 7 to 50. Participants take the drug or a placebo four times daily for 21 days. The goal is to see if it safely improves symptoms like fatigue, brain fo…

Matched conditions: LONG COVID-19

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

LONG COVID-19

Get alerted when new LONG COVID-19 trials appear

Could a gut pill ease long COVID? new trial tests larazotide